Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection

by Alexander G. Allen, Alexander G. Allen, Cheng-Han Chung, Cheng-Han Chung, Andrew Atkins, Andrew Atkins, Will Dampier, Will Dampier, Will Dampier, Kamel Khalili, Kamel Khalili, Michael R. Nonnemacher, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl
Published 2018-12-01

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy

by Andrew Atkins, Andrew Atkins, Cheng-Han Chung, Cheng-Han Chung, Alexander G. Allen, Alexander G. Allen, Will Dampier, Will Dampier, Theodore E. Gurrola, Theodore E. Gurrola, Ilker K. Sariyer, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl
Published 2021-08-01

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy

by Cheng-Han Chung, Cheng-Han Chung, Alexander G. Allen, Alexander G. Allen, Andrew Atkins, Andrew Atkins, Robert W. Link, Robert W. Link, Michael R. Nonnemacher, Michael R. Nonnemacher, Michael R. Nonnemacher, Will Dampier, Will Dampier, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl
Published 2021-03-01

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing

by Neil T. Sullivan, Neil T. Sullivan, Alexander G. Allen, Alexander G. Allen, Andrew J. Atkins, Andrew J. Atkins, Cheng-Han Chung, Cheng-Han Chung, Will Dampier, Will Dampier, Will Dampier, Michael R. Nonnemacher, Michael R. Nonnemacher, Michael R. Nonnemacher, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl, Brian Wigdahl
Published 2020-08-01

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites

by Cheng-Han Chung, Alexander G. Allen, Andrew J. Atkins, Neil T. Sullivan, Greg Homan, Robert Costello, Rebekah Madrid, Michael R. Nonnemacher, Will Dampier, Brian Wigdahl
Published 2020-09-01